drugset / Trial / NCT00368498
A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether the standard dosage of teicoplanin is adequate to produce timely the trough level \> 10 mg/L, which is considered to be effective in the treatment of methicillin-resistant Staphyllococcus aureus (MRSA) bacteremia.
Timeline
- Start
- 2006-06
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teicoplanin | Other / unclassified | 6 mg/kg | — |
| Subject | Teicoplanin | Other / unclassified | 12 mg/kg | — |